Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver

被引:60
|
作者
Wulf, J [1 ]
Hädinger, U [1 ]
Oppitz, U [1 ]
Thiele, W [1 ]
Flentje, M [1 ]
机构
[1] Univ Wurzburg, Dept Radiotherapy, D-97080 Wurzburg, Germany
关键词
stereotactic radiotherapy; stereotactic body frame; conformal radiotherapy; computed tomography simulation; treatment accuracy; dose-volume histogram;
D O I
10.1016/S0167-8140(02)00372-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Previous analyses of target reproducibility in extracranial stereotactic radiotherapy have revealed standard security margins for planning target volume (PTV) definition of 5 mm in axial and 5-10 mm in longitudinal direction. In this study the reproducibility of the clinical target volume (CTV) of lung and liver tumors within the PTV over the complete course of hypofractionated treatment is evaluated. The impact of target mobility on dose to the CTV is assessed by dose-volume histograms (DVH). Materials and methods: Twenty-two pulmonary and 21 hepatic targets were treated with three stercotactic fractions of 10 Gy to the PTV-enclosing 100%-isodose with normalization to 150% at the isocenter. A conformal dose distribution was related to the PTV, which was defined by margins of 5-10 mm added to the CTV. Prior to each fraction a computed tomography (CT)-simulation over the complete target volume was performed resulting in a total of 60 CT-simulations for lung and 58 CT-simulations for hepatic targets. The CTV from each CT-simulation was segmented and matched with the CT-study used for treatment planning. A DVH of the simulated CTV was calculated for each fraction. The target coverage (TC) of dose to the simulated CTV was defined as the proportion of the CTV receiving at least the reference dose (100%). Results: A decrease of TC to <95% was found in 3/60 simulations (5%) of pulmonary and 7/58 simulations (12%) of hepatic targets. In two of 22 pulmonary targets (9%) and in four of 21 hepatic targets (19%) a TC of <95% occurred in at least one fraction. At risk for a 3 decreased TC <95% were pulmonary targets with increased breathing mobility and hepatic targets with a CTV exceeding 100 cm(3). Conclusions: Target reproducibility was precise within the reference isodose in 91% of lung and 81% of liver tumors with a TC of the complete CTV greater than or equal to95% at each fraction of treatment. Pulmonary targets with increased breathing mobility and liver tumors >100 cm(3) are at risk for target deviation exceeding the standard security margins for PTV-definition at least for one fraction and require individual evaluation of sufficient margins. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 50 条
  • [1] Stereotactic Radiotherapy of Targets in the Lung and Liver
    Jörn Wulf
    Ulrich Hädinger
    Ulrich Oppitz
    Wibke Thiele
    Rea Ness-Dourdoumas
    Michael Flentje
    [J]. Strahlentherapie und Onkologie, 2001, 177 : 645 - 655
  • [2] Stereotactic radiotherapy of targets in the lung and liver
    Wulf, J
    Hädinger, U
    Oppitz, U
    Thiele, W
    Ness-Dourdoumas, R
    Flentje, M
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (12) : 645 - +
  • [3] Image-guidance technique comparison on respiratory reproducibility and dose indexes for stereotactic body radiotherapy in lung tumor
    Kanzaki, Ryuji
    Araki, Fujio
    Kawamura, Shinji
    [J]. MEDICAL DOSIMETRY, 2019, 44 (04) : 385 - 393
  • [4] On the dose to a moving target in stereotactic ablative body radiotherapy to lung tumors
    Feygelman, V.
    Dilling, T. J.
    Moros, E. G.
    Zhang, G. G.
    [J]. MICRO-MINI & NANO-DOSIMETRY & INNOVATIVE TECHNOLOGIES IN RADIATION THERAPY (MMND&ITRO2016), 2017, 777
  • [5] ROBOTIC STEREOTACTIC RADIOTHERAPY FOR LUNG TUMOR : DOSE AND TOXICITY EVALUATION.
    Panizzoni, G. A.
    Bolzicco, G.
    Baiocchi, C.
    Testolin, A.
    Mari, C.
    Favretto, M. S.
    Messina, F.
    Scalchi, P.
    Cavedon, C.
    Cora, S.
    Colombo, F.
    Francescon, P.
    Guglielmi, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S290 - S290
  • [6] Impact of respiratory motion on the calculation of lung dose in stereotactic body radiotherapy
    Lawrence, K. S.
    Picone, J. R.
    Yang, T. J.
    Trumpore, S.
    Nath, R.
    Decker, R. H.
    Wilson, L. D.
    Chen, Z. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S675 - S676
  • [7] Survival Impact of Cardiac Dose Following Lung Stereotactic Body Radiotherapy
    Wong, Olive Y.
    Yau, Vivian
    Kang, Julie
    Glick, Daniel
    Lindsay, Patricia
    Le, Lisa W.
    Sun, Alexander
    Bezjak, Andrea
    Cho, B. C. John
    Hope, Andrew
    Giuliani, Meredith
    [J]. CLINICAL LUNG CANCER, 2018, 19 (02) : E241 - E246
  • [8] Reproducibility of the liver in stereotactic radiotherapy using abdominal compression
    Zwiers, D.
    Koekoek, S.
    Bouwhuis-Scholten, A.
    Piersma, H.
    Van Dieren, E.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S106 - S106
  • [9] Reproducibility and accuracy of a target motion mitigation technique for dose-escalated prostate stereotactic body radiotherapy
    Greco, Carlo
    Stroom, Joep
    Vieira, Sandra
    Mateus, Dalila
    Cardoso, Maria Joao
    Soares, Ana
    Pares, Oriol
    Pimentel, Nuno
    Louro, Vasco
    Nunes, Beatriz
    Kociolek, Justyna
    Fuks, Zvi
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 160 : 240 - 249
  • [10] Is internal target volume accurate for dose evaluation in lung cancer stereotactic body radiotherapy?
    Peng, Jiayuan
    Zhang, Zhen
    Wang, Jiazhou
    Xie, Jiang
    Hu, Weigang
    [J]. ONCOTARGET, 2016, 7 (16) : 22523 - 22530